Back to Search
Start Over
Rituximab and intense chemotherapy in a patient with defective cell mediated immunity due to cartilage-hair hypoplasia and Burkitt lymphoma.
- Source :
-
Pediatric blood & cancer [Pediatr Blood Cancer] 2020 Jul; Vol. 67 (7), pp. e28259. Date of Electronic Publication: 2020 May 13. - Publication Year :
- 2020
- Subjects :
- Adolescent
Burkitt Lymphoma complications
Burkitt Lymphoma immunology
Burkitt Lymphoma pathology
Cyclophosphamide administration & dosage
Doxorubicin administration & dosage
Female
Hair immunology
Hair pathology
Hirschsprung Disease complications
Hirschsprung Disease immunology
Hirschsprung Disease pathology
Humans
Methotrexate administration & dosage
Osteochondrodysplasias complications
Osteochondrodysplasias drug therapy
Osteochondrodysplasias immunology
Osteochondrodysplasias pathology
Prednisone administration & dosage
Primary Immunodeficiency Diseases complications
Primary Immunodeficiency Diseases immunology
Primary Immunodeficiency Diseases pathology
Prognosis
Rituximab administration & dosage
Vincristine administration & dosage
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Burkitt Lymphoma drug therapy
Hair abnormalities
Hirschsprung Disease drug therapy
Immunity, Cellular drug effects
Immunocompromised Host drug effects
Osteochondrodysplasias congenital
Primary Immunodeficiency Diseases drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1545-5017
- Volume :
- 67
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Pediatric blood & cancer
- Publication Type :
- Report
- Accession number :
- 32400949
- Full Text :
- https://doi.org/10.1002/pbc.28259